Management of orthopaedic surgery in rare bleeding disorders

S. M. Siboni, E. Biguzzi, G. Pasta, P. M. Mannucci, C. Mistretta, N. N. Fantini, L. P. Solimeno, F. Peyvandi

Research output: Contribution to journalArticle

Abstract

Knowledge regarding the management of orthopaedic surgery in patients with rare bleeding disorders (RBDs) is limited. Retrospective data collection and analysis of 35 orthopaedic procedures (6 minor and 29 major) carried out in 22 patients with RBD between 1982 and 2013. These surgeries were performed using heterogeneous regimens of hemostatic therapy, except for seven procedures performed with no hemostatic treatment in four patients with mild factor deficiency. Of the 28 procedures carried out with hemostatic treatment, nine (32%) were performed using replacement therapy with dosages of concentrates of the deficient factor aimed to achieve perioperative plasma levels judged to be compatible with hemostasis; three (11%) using factor replacement therapy associated with fresh frozen plasma (FFP); four (14%) using recombinant activated factor VII; four (14%) using virus inactivated plasma alone; three (11%) using virus inactivated plasma associated with desmopressin; one (4%) using FFP alone; and four (14%) procedures using tranexamic acid alone. Bleeding complications occurred in 7 of 35 procedures (20%) involving five patients. Prophylaxis of venous thromboembolism was performed only in one case with no excessive bleeding, but two patients not on thromboprophylaxis developed superficial thrombophlebitis. A satisfactory control of hemostasis was achieved in most patients. In some of those characterized by mild factor deficiency (FVII, FXI) hemostatic treatment could be avoided in some instances. The control of hemostasis combined with an adequate surgical technique is needed for the successful outcome of orthopaedic surgery in RBDs that requires the involvement of specialized haemophilia centres.

Original languageEnglish
Pages (from-to)693-701
Number of pages9
JournalHaemophilia
Volume20
Issue number5
DOIs
Publication statusPublished - Sep 1 2014

Fingerprint

Orthopedics
Hemostatics
Hemorrhage
Hemostasis
Therapeutics
Orthopedic Procedures
Viruses
Tranexamic Acid
Knowledge Management
Deamino Arginine Vasopressin
Factor VIIa
Thrombophlebitis
Venous Thromboembolism
Hemophilia A

Keywords

  • arthropathy
  • orthopaedic surgery
  • rare coagulation disorders

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Management of orthopaedic surgery in rare bleeding disorders. / Siboni, S. M.; Biguzzi, E.; Pasta, G.; Mannucci, P. M.; Mistretta, C.; Fantini, N. N.; Solimeno, L. P.; Peyvandi, F.

In: Haemophilia, Vol. 20, No. 5, 01.09.2014, p. 693-701.

Research output: Contribution to journalArticle

@article{83991fe03f564233baff695ba8bcc467,
title = "Management of orthopaedic surgery in rare bleeding disorders",
abstract = "Knowledge regarding the management of orthopaedic surgery in patients with rare bleeding disorders (RBDs) is limited. Retrospective data collection and analysis of 35 orthopaedic procedures (6 minor and 29 major) carried out in 22 patients with RBD between 1982 and 2013. These surgeries were performed using heterogeneous regimens of hemostatic therapy, except for seven procedures performed with no hemostatic treatment in four patients with mild factor deficiency. Of the 28 procedures carried out with hemostatic treatment, nine (32{\%}) were performed using replacement therapy with dosages of concentrates of the deficient factor aimed to achieve perioperative plasma levels judged to be compatible with hemostasis; three (11{\%}) using factor replacement therapy associated with fresh frozen plasma (FFP); four (14{\%}) using recombinant activated factor VII; four (14{\%}) using virus inactivated plasma alone; three (11{\%}) using virus inactivated plasma associated with desmopressin; one (4{\%}) using FFP alone; and four (14{\%}) procedures using tranexamic acid alone. Bleeding complications occurred in 7 of 35 procedures (20{\%}) involving five patients. Prophylaxis of venous thromboembolism was performed only in one case with no excessive bleeding, but two patients not on thromboprophylaxis developed superficial thrombophlebitis. A satisfactory control of hemostasis was achieved in most patients. In some of those characterized by mild factor deficiency (FVII, FXI) hemostatic treatment could be avoided in some instances. The control of hemostasis combined with an adequate surgical technique is needed for the successful outcome of orthopaedic surgery in RBDs that requires the involvement of specialized haemophilia centres.",
keywords = "arthropathy, orthopaedic surgery, rare coagulation disorders",
author = "Siboni, {S. M.} and E. Biguzzi and G. Pasta and Mannucci, {P. M.} and C. Mistretta and Fantini, {N. N.} and Solimeno, {L. P.} and F. Peyvandi",
year = "2014",
month = "9",
day = "1",
doi = "10.1111/hae.12387",
language = "English",
volume = "20",
pages = "693--701",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "5",

}

TY - JOUR

T1 - Management of orthopaedic surgery in rare bleeding disorders

AU - Siboni, S. M.

AU - Biguzzi, E.

AU - Pasta, G.

AU - Mannucci, P. M.

AU - Mistretta, C.

AU - Fantini, N. N.

AU - Solimeno, L. P.

AU - Peyvandi, F.

PY - 2014/9/1

Y1 - 2014/9/1

N2 - Knowledge regarding the management of orthopaedic surgery in patients with rare bleeding disorders (RBDs) is limited. Retrospective data collection and analysis of 35 orthopaedic procedures (6 minor and 29 major) carried out in 22 patients with RBD between 1982 and 2013. These surgeries were performed using heterogeneous regimens of hemostatic therapy, except for seven procedures performed with no hemostatic treatment in four patients with mild factor deficiency. Of the 28 procedures carried out with hemostatic treatment, nine (32%) were performed using replacement therapy with dosages of concentrates of the deficient factor aimed to achieve perioperative plasma levels judged to be compatible with hemostasis; three (11%) using factor replacement therapy associated with fresh frozen plasma (FFP); four (14%) using recombinant activated factor VII; four (14%) using virus inactivated plasma alone; three (11%) using virus inactivated plasma associated with desmopressin; one (4%) using FFP alone; and four (14%) procedures using tranexamic acid alone. Bleeding complications occurred in 7 of 35 procedures (20%) involving five patients. Prophylaxis of venous thromboembolism was performed only in one case with no excessive bleeding, but two patients not on thromboprophylaxis developed superficial thrombophlebitis. A satisfactory control of hemostasis was achieved in most patients. In some of those characterized by mild factor deficiency (FVII, FXI) hemostatic treatment could be avoided in some instances. The control of hemostasis combined with an adequate surgical technique is needed for the successful outcome of orthopaedic surgery in RBDs that requires the involvement of specialized haemophilia centres.

AB - Knowledge regarding the management of orthopaedic surgery in patients with rare bleeding disorders (RBDs) is limited. Retrospective data collection and analysis of 35 orthopaedic procedures (6 minor and 29 major) carried out in 22 patients with RBD between 1982 and 2013. These surgeries were performed using heterogeneous regimens of hemostatic therapy, except for seven procedures performed with no hemostatic treatment in four patients with mild factor deficiency. Of the 28 procedures carried out with hemostatic treatment, nine (32%) were performed using replacement therapy with dosages of concentrates of the deficient factor aimed to achieve perioperative plasma levels judged to be compatible with hemostasis; three (11%) using factor replacement therapy associated with fresh frozen plasma (FFP); four (14%) using recombinant activated factor VII; four (14%) using virus inactivated plasma alone; three (11%) using virus inactivated plasma associated with desmopressin; one (4%) using FFP alone; and four (14%) procedures using tranexamic acid alone. Bleeding complications occurred in 7 of 35 procedures (20%) involving five patients. Prophylaxis of venous thromboembolism was performed only in one case with no excessive bleeding, but two patients not on thromboprophylaxis developed superficial thrombophlebitis. A satisfactory control of hemostasis was achieved in most patients. In some of those characterized by mild factor deficiency (FVII, FXI) hemostatic treatment could be avoided in some instances. The control of hemostasis combined with an adequate surgical technique is needed for the successful outcome of orthopaedic surgery in RBDs that requires the involvement of specialized haemophilia centres.

KW - arthropathy

KW - orthopaedic surgery

KW - rare coagulation disorders

UR - http://www.scopus.com/inward/record.url?scp=84929518102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929518102&partnerID=8YFLogxK

U2 - 10.1111/hae.12387

DO - 10.1111/hae.12387

M3 - Article

VL - 20

SP - 693

EP - 701

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 5

ER -